Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill: 2011-2025

Historic Goodwill for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $51.6 million.

  • Myriad Genetics' Goodwill fell 81.98% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 81.98%. This contributed to the annual value of $286.3 million for FY2024, which is 0.38% down from last year.
  • As of Q3 2025, Myriad Genetics' Goodwill stood at $51.6 million, which was down 0.00% from $51.6 million recorded in Q2 2025.
  • Myriad Genetics' Goodwill's 5-year high stood at $328.3 million during Q1 2021, with a 5-year trough of $51.6 million in Q2 2025.
  • Moreover, its 3-year median value for Goodwill was $286.3 million (2025), whereas its average is $244.0 million.
  • Its Goodwill has fluctuated over the past 5 years, first grew by 21.18% in 2023, then crashed by 81.98% in 2025.
  • Myriad Genetics' Goodwill (Quarterly) stood at $239.2 million in 2021, then climbed by 19.90% to $286.8 million in 2022, then grew by 0.21% to $287.4 million in 2023, then declined by 0.38% to $286.3 million in 2024, then plummeted by 81.98% to $51.6 million in 2025.
  • Its Goodwill was $51.6 million in Q3 2025, compared to $51.6 million in Q2 2025 and $286.3 million in Q1 2025.